MediumAges 30-60

Aging Population Portfolio

Invests in healthcare, pharmaceuticals, and senior care industries benefiting from global demographic aging trends

Expected Return

8-10% annually

Expected Dividend

2.5% annually

Rebalancing

Quarterly

Asset Allocation

XLV (25%)

VHT (20%)

PJP (20%)

OLD (20%)

IHF (15%)

XLV

Broad healthcare sector exposure

25%

VHT

Vanguard healthcare ETF for diversified medical industry coverage

20%

PJP

Pharmaceutical industry focus for drug development and sales growth

20%

OLD

Senior care and elderly services companies

20%

IHF

Healthcare facilities and managed care organizations

15%

Advantages

✓Backed by a clear and irreversible demographic trend
✓Defensive characteristics with lower correlation to economic cycles
✓Stable and growing demand driven by aging populations worldwide

Risks

!Vulnerability to healthcare policy and reimbursement changes
!Pressure from rising healthcare costs and insurance reform
!Tightening pharmaceutical regulations may limit pricing power

Allocation by Investment Amount

If investing $1,000

XLV$250

VHT$200

PJP$200

OLD$200

IHF$150

If investing $5,000

XLV$1250

VHT$1000

PJP$1000

OLD$1000

IHF$750

If investing $10,000

XLV$2500

VHT$2000

PJP$2000

OLD$2000

IHF$1500